A
Ali Khamesipour
Researcher at Tehran University of Medical Sciences
Publications - 246
Citations - 6619
Ali Khamesipour is an academic researcher from Tehran University of Medical Sciences. The author has contributed to research in topics: Cutaneous leishmaniasis & Leishmania major. The author has an hindex of 41, co-authored 235 publications receiving 5803 citations. Previous affiliations of Ali Khamesipour include University of California, Irvine & University of Tehran.
Papers
More filters
Journal ArticleDOI
Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data
Jens U. Ruggeberg,Michael Gold,José-María Bayas,Michael D. Blum,Jan Bonhoeffer,Sheila Fallon Friedlander,Glacus de Souza Brito,Ulrich Heininger,Babatunde Imoukhuede,Ali Khamesipour,Michel Erlewyn-Lajeunesse,Susana Martin,Mika J. Mäkelä,Patricia Nell,Vitali Pool,Nicholas Simpson +15 more
TL;DR: The Brighton Collaboration Anaphylaxis Working Group aims to provide a platform for international co-operation and co-ordination in the furtherance of knowledge and understanding of anaphylactic shock.
Journal ArticleDOI
Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites.
TL;DR: This is the first report of proven resistant parasites contributing to treatment failure for cutaneous leishmaniasis and shows that primary Glucantime-resistant L. tropica field isolates are now frequent in Iran.
Journal ArticleDOI
Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran.
Iraj Sharifi,Alireza Fekri,Mohammad Reza Aflatoonian,Ali Khamesipour,Abolhassan Nadim,Mohammad-Reza Ahmadi Mousavi,Ali Momeni,Y Dowlati,Tore Godal,Fabio Zicker,Pete Smith,Farrokh Modabber +11 more
TL;DR: A single dose of ALM + BCG was safe and more immunogenic than BCG alone, as measured by leishmanin skin test, and the preferential protective effect in boys may have resulted from a greater booster effect produced by repeated exposure to infected sandflies.
Journal Article
Leishmaniasis vaccine candidates for development: a global overview.
TL;DR: This review presents only the vaccines in use and those in development for use in dogs or humans, and is not an exhaustive review of vaccine discovery or the principles of clinical immunology underlying vaccine development.
Journal ArticleDOI
Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis.
Ali Khamesipour,Yahya Dowlati,Ali Asilian,Reza Hashemi-Fesharki,Amir Javadi,Sassan Noazin,Farrokh Modabber +6 more
TL;DR: LZ used as live challenge to test vaccine candidates reduces the required sample size, is cost effective for surrogate markers studies and will induce protection in the participants who are not protected by candidate vaccines.